Navigation Links
Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
Date:3/5/2009

SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- On the surface, the thick, red, scaly, itchy plaques of psoriasis -- which have been shown to have a significant negative impact on a person's overall quality of life -- may not appear to pose a serious health risk for patients. However, a growing body of research suggests that psoriasis patients are at an increased risk of developing serious medical conditions, including cardiovascular disease and diabetes, particularly when their psoriasis is severe.

Speaking today at the 67th Annual Meeting of the American Academy of Dermatology (Academy), dermatologist Joel M. Gelfand, MD, MSCE, FAAD, assistant professor of dermatology at the University of Pennsylvania School of Medicine in Philadelphia, spoke about this complex skin condition and its relationship to other serious medical conditions.

Dr. Gelfand explained that for the last two decades, research has shown that excessive inflammation is a critical feature of psoriasis. This discovery has led to innovative approaches to treating psoriasis, with therapies targeting selected areas of the immune system that are over-active in psoriasis patients. Excess inflammation also is present in other common conditions, such as hardening of the arteries, heart attacks, stroke, obesity and diabetes -- which may explain why some psoriasis patients may be at an increased risk for developing these other serious conditions.

Studies show the link between patients with severe psoriasis and diabetes, heart attack and coronary artery disease occurs independent of traditional risk factors for these other conditions -- such as obesity, smoking or high blood pressure.

Furthermore, Dr. Gelfand's recent research suggests that patients with severe psoriasis may have shorter life expectancies than non-psoriasis patients. Specifically, he found that those with severe psoriasis may die three to five years earlie
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
2. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
3. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
4. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
5. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
6. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
7. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
8. OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
11. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)...  TRACE International today released its Global Enforcement ... against individuals and government or business entities for bribery ... 2012 is the third in an annual series ... "Although the number of outbound enforcement actions fell ... priority," said Alexandra Wrage , TRACE ...
(Date:5/20/2013)... EL SEGUNDO, Calif. , May 20, 2013 /PRNewswire/ ... helped perfect for use both in space and on ... of Fame. The technology assures high ... by compact and low-power ultrasound units, like those used ... ultrasound is already the diagnostic imaging solution of choice ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Wyle Aided System Gets Named to Space Technology Hall of Fame 2Wyle Aided System Gets Named to Space Technology Hall of Fame 3
... Pharmaceuticals, Inc. (Nasdaq: MAPP ) today reported ... effects on pulmonary artery pressure of LEVADEX™, dihydroergotamine mesylate ... there was no statistically significant difference between the LEVADEX ... artery pressure over two hours after administration. LEVADEX is ...
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader ... company overview at Stifel Nicolaus, 2010 Healthcare Conference on Thursday, ... Seasons Hotel in Boston, MA. A live audio ... & Media" section of the Company,s Web site, www.isispharm.com ...
Cached Medicine Technology:MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 2MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 3MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 4
(Date:5/20/2013)... 2013 For the third consecutive ... of Frederick Award in the Professional Standards Review ... , The USCA "Best of Local Business" Award ... Each year, the USCA identifies companies that they ... local community and business category. These are local ...
(Date:5/20/2013)... The new healthcare bill proposes to ... all Americans. However, not all the conditions were to ... might take up to 2014 to show anything. ... states are currently moving forward to implement the health ... Iowa, Michigan, New Hampshire, and West Virginia. HHS will ...
(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and sports ... that can help them overcome one of the most spread ... Natural Vitiligo Treatment System has created a buzz on ... received from the persons who have tried it. Its principles ... interviewed some of the people who tried it and managed ...
(Date:5/20/2013)... People are so busy these days, running ... through the roof and are contributing to a number of ... mean the difference between life and death. Speakers at the ... May will share valuable, practical tools people can use to ... around them for social good. , Organised by V ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... Foundation will be holding a ... Lansing on June 10th. , ... 10th, 6:30 p.m. – 8 ... (Across from Sparrow Hospital),                  ...
Breaking Medicine News(10 mins):Health News:A2LA Receives 2013 Best of Frederick Award 2Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2
... ... system that automatically matches the right clients with the right lenders making the whole ... conversions for retailers. , ... Orlando, FL (PRWEB) June 17, 2009 -- The world of Equipment Leasing/Financing is ...
... ORANGE COUNTY, Calif., June 17 Applied Medical, a ... in the Premier healthcare alliance ,s ... in healthcare while highlighting healthcare industry suppliers committed to ... Innovation Celebration highlights innovative solutions that bring a positive ...
... rescue manager won contest to clone beloved pet Trakr, hero of ... Can you clone a hero? Retired ... dog and 9-11 hero, Trakr, will receive five answers to that ... biotech company that is offering the first commercial dog cloning service ...
... Focus on promoting ... ... signed a Memorandum of Understanding (MOU) to promote healthcare travel in the Pacific Asia region. ... and drive more integration between the travel and healthcare industries., , , , ,Under the ...
... Dr. Bryan Selkin, the ... new state of the art location at 5044 Tennyson in Plano. Dr. Bryan Selkin will ... ... Selkin, the Chief Dermatologist of the Dermatology Center of Plano will be relocating his practice to ...
... Withdraws Two Cold Remedy Nasal Products Citing Commitment to Consumer ... Matrixx Initiatives, Inc. (Nasdaq: MTXX ) has ... U.S. Food and Drug Administration about two of its 19 ... Zicam Cold Remedy Swabs. The warning letter cited consumer reports ...
Cached Medicine News:Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 2Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 3Health News:Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement, Innovation 2Health News:Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement, Innovation 3Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 2Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 3Health News:New State of the Art Dermatology Center in Plano TX 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3
Inquire...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... provides an ideal treatment for ... such as the great and ... wavelength targets water in the ... means a much more comfortable ...
...
Medicine Products: